17-7445306-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000747.3(CHRNB1):​c.95A>G​(p.Glu32Gly) variant causes a missense change. The variant allele was found at a frequency of 0.319 in 1,612,188 control chromosomes in the GnomAD database, including 91,748 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 6030 hom., cov: 32)
Exomes 𝑓: 0.33 ( 85718 hom. )

Consequence

CHRNB1
NM_000747.3 missense

Scores

7
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 6.06

Publications

27 publications found
Variant links:
Genes affected
CHRNB1 (HGNC:1961): (cholinergic receptor nicotinic beta 1 subunit) The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome. [provided by RefSeq, Jul 2008]
CHRNB1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 2C
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • congenital myasthenic syndrome 1A
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • congenital myasthenic syndrome 2A
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031630695).
BP6
Variant 17-7445306-A-G is Benign according to our data. Variant chr17-7445306-A-G is described in ClinVar as Benign. ClinVar VariationId is 128754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000747.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNB1
NM_000747.3
MANE Select
c.95A>Gp.Glu32Gly
missense
Exon 2 of 11NP_000738.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNB1
ENST00000306071.7
TSL:1 MANE Select
c.95A>Gp.Glu32Gly
missense
Exon 2 of 11ENSP00000304290.2
ENSG00000272884
ENST00000575331.1
TSL:1
n.4893A>G
non_coding_transcript_exon
Exon 3 of 3
CHRNB1
ENST00000572857.5
TSL:4
c.95A>Gp.Glu32Gly
missense
Exon 2 of 6ENSP00000461402.1

Frequencies

GnomAD3 genomes
AF:
0.242
AC:
36844
AN:
151998
Hom.:
6033
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0631
Gnomad AMI
AF:
0.396
Gnomad AMR
AF:
0.233
Gnomad ASJ
AF:
0.355
Gnomad EAS
AF:
0.00251
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.282
GnomAD2 exomes
AF:
0.248
AC:
60334
AN:
243398
AF XY:
0.254
show subpopulations
Gnomad AFR exome
AF:
0.0517
Gnomad AMR exome
AF:
0.164
Gnomad ASJ exome
AF:
0.350
Gnomad EAS exome
AF:
0.000658
Gnomad FIN exome
AF:
0.272
Gnomad NFE exome
AF:
0.364
Gnomad OTH exome
AF:
0.291
GnomAD4 exome
AF:
0.327
AC:
478142
AN:
1460072
Hom.:
85718
Cov.:
52
AF XY:
0.323
AC XY:
234714
AN XY:
726302
show subpopulations
African (AFR)
AF:
0.0523
AC:
1749
AN:
33464
American (AMR)
AF:
0.171
AC:
7638
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.357
AC:
9318
AN:
26110
East Asian (EAS)
AF:
0.000655
AC:
26
AN:
39678
South Asian (SAS)
AF:
0.121
AC:
10433
AN:
86198
European-Finnish (FIN)
AF:
0.278
AC:
14608
AN:
52548
Middle Eastern (MID)
AF:
0.321
AC:
1853
AN:
5768
European-Non Finnish (NFE)
AF:
0.373
AC:
414317
AN:
1111426
Other (OTH)
AF:
0.302
AC:
18200
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
20258
40516
60774
81032
101290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12572
25144
37716
50288
62860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.242
AC:
36826
AN:
152116
Hom.:
6030
Cov.:
32
AF XY:
0.234
AC XY:
17413
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.0630
AC:
2613
AN:
41506
American (AMR)
AF:
0.233
AC:
3561
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
1232
AN:
3472
East Asian (EAS)
AF:
0.00252
AC:
13
AN:
5162
South Asian (SAS)
AF:
0.112
AC:
539
AN:
4824
European-Finnish (FIN)
AF:
0.275
AC:
2911
AN:
10590
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24907
AN:
67956
Other (OTH)
AF:
0.279
AC:
588
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1336
2673
4009
5346
6682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.332
Hom.:
14866
Bravo
AF:
0.231
TwinsUK
AF:
0.379
AC:
1404
ALSPAC
AF:
0.369
AC:
1422
ESP6500AA
AF:
0.0641
AC:
282
ESP6500EA
AF:
0.354
AC:
3042
ExAC
AF:
0.244
AC:
29534
Asia WGS
AF:
0.0540
AC:
186
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 07, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Feb 14, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myasthenic syndrome 2A Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Congenital myasthenic syndrome 4C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.31
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.95
D
MetaRNN
Benign
0.0032
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L
PhyloP100
6.1
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.6
D
REVEL
Uncertain
0.32
Sift
Benign
0.26
T
Sift4G
Benign
0.18
T
Polyphen
0.77
P
Vest4
0.11
MPC
0.70
ClinPred
0.037
T
GERP RS
5.4
PromoterAI
0.037
Neutral
Varity_R
0.24
gMVP
0.53
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17856697; hg19: chr17-7348625; COSMIC: COSV53439803; COSMIC: COSV53439803; API